Patents
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
11/2002
11/07/2002CA2445702A1 Control of compactability through crystallization
11/07/2002CA2445584A1 Injectable pamidronate disodium
11/07/2002CA2445310A1 Multivalent vaccine comprising an hiv antigen and an hsv antigen and/or an hpv antigen
11/07/2002CA2445290A1 A pharmaceutical tablet having a high api content
11/07/2002CA2445120A1 Devices for the intradermal administration of influenza vaccines
11/07/2002CA2444483A1 Diagnostic imaging compositions, their methods of synthesis and use
11/07/2002CA2444383A1 Therapeutic agent/ligand conjugate compositions, their methods of synthesis and use
11/07/2002CA2443381A1 Use of azithromycin for the manufacture of a medicament for treatment of non-infective inflammatory diseases
11/06/2002EP1254956A2 Novel osteoinductive compositions
11/06/2002EP1254944A1 Dry compositions containing hydrophobic amino acid
11/06/2002EP1254935A2 Gelatins with good slipping properties, processes for their preparation and their uses
11/06/2002EP1254666A1 Stable antibody compositions and injection preparations
11/06/2002EP1254663A1 Anti-virus agent
11/06/2002EP1254659A1 Stable emulsion compositions
11/06/2002EP1254237A2 Aggregate-free urate oxidase for preparation of non-immunogenic polymer conjugates
11/06/2002EP1254229A1 Vector constructs for gene-therapy mediated radionuclide therapy of undifferentiated and medullary thyroid carcinomas and non-thyroidal tumours and the metastases thereof
11/06/2002EP1254179A1 An in vivo screen using chemical inducers of dimerization
11/06/2002EP1254145A1 N,o-amidomalonate platinum complexes
11/06/2002EP1254143A2 Lipid-based drug delivery systems
11/06/2002EP1253950A2 Sterile water generator
11/06/2002EP1253943A2 Photodynamic therapy for treating conditions of the eye
11/06/2002EP1253939A1 In vivo ctl elicitation by heat shock protein fusion proteins maps to a discrete atp binding domain and is cd4+ t cell-independent
11/06/2002EP1253937A2 Methods of therapy with thrombin derived peptides
11/06/2002EP1253936A2 Microencapsulation and sustained release of biologically active agent
11/06/2002EP1253932A2 Botulinum toxin pharmaceutical compositions
11/06/2002EP1253928A2 Novel haptotactic peptides
11/06/2002EP1253918A2 Compositions including modafinil for treatment of attention deficit hyperactivity disorder and multiple sclerosis fatigue
11/06/2002EP1253911A1 Method for loading a red blood cell with an agent
11/06/2002EP1253903A2 Surfactant free topical compositions and method for rapid preparation thereof
11/06/2002EP1253824A2 Fluid insecticidal formulations for treatment of parasitic insect larvae by dermal application
11/06/2002EP1107731B1 Synthetic tear fluid
11/06/2002EP0951287B1 Oral composition comprising 5-aminosalicyclic acid
11/06/2002EP0918799B1 Amylose products as matrix former for programmed release systems, process for preparing these amylose products, and process for making programmed release systems
11/06/2002EP0909277A3 Humanized antibodies that bind to the same antigen as bound by antibody nr-lu-13, and their use in pretargeting methods
11/06/2002EP0843558B1 Composition for enhanced uptake of polar drugs from the colon
11/06/2002EP0837682B1 Therapeutic use of 1-amino-3-(n,n-dimethylamino)-propyliden-1,1-bisphosphonic acid and its salts
11/06/2002EP0777467B1 Aerosol drug formulations containing polyglycolyzed glycerides
11/06/2002EP0746307B1 Cosmetic compositions
11/06/2002EP0726758B1 Peptides for inducing cytotoxic t lymphocyte responses to hepatitis b virus
11/06/2002EP0717618B1 Stabilized tablet formulation
11/06/2002CN1378536A Neutral-cationic lipid for nuelci acid and drug delivery
11/06/2002CN1378499A Injection molding method for neutral and acidic-group containing (meth) acrylate copolymers
11/06/2002CN1378471A Dual adhesive transdermal drug delivery system
11/06/2002CN1378459A Treatment of auto immune diseases with antagonists which bind to B cell surface markers
11/06/2002CN1378458A Use of TGF-beta and growth factors in treatment and prevention of diseases of intestinal mucosa
11/06/2002CN1378452A Orally disintegrating composition containing mirtazapine
11/06/2002CN1378446A Method of inhibiting amyloid protein aggregation and imaging amyloid deposits
11/06/2002CN1378445A Drug releasing biodegradable fiber implant
11/06/2002CN1378444A Foam coating and foam coated compositions
11/06/2002CN1378443A Cationic liposome delivery of taxanes to angiogenic blood vessels
11/06/2002CN1377880A Compound for curing vascular complication, its preparing method and treating use
11/06/2002CN1377706A Ocular in-situ gel preparatino with proper phase conversion temperature
11/06/2002CN1377689A Traditional Chinese medicine injection for curing cardiovascular and cerebrovascular diseases and fundus disease and its preparing method
11/06/2002CN1377639A Method for wrapping kmedicine by liposome
11/06/2002CN1093855C New compsn. containing acid-labile benzimidazole and process for its prepn.
11/06/2002CN1093762C Aqueous suspension of 9-hydroxyrisperidone fatty and esters
11/05/2002WO2001085821A1 Polyurethane and the use thereof for modifying rheological properties
11/05/2002US6476243 Perfluorinated esters of alkanoyl L-carnitine for the preparation of cationic lipids for the intracellular delivery of pharmacologically active compounds
11/05/2002US6476204 Dextran-maleic acid monoesters and hydrogels based thereon
11/05/2002US6476156 Biodegradable triblock copolymers and process for their preparation
11/05/2002US6476079 Devices for the delivery of drugs having antiprogestinic properties
11/05/2002US6476068 Platinum derivative pharmaceutical formulations
11/05/2002US6476043 Use of camptothecin derivatives, with reduced gastrointestinal toxicity
11/05/2002US6476020 Imidazo-benzazepine compounds, their compositions and uses
11/05/2002US6476010 Orally administering to a post-menopausal woman a fat soluble vitamin and a fat soluble vitamin absorption increasing effective amount of l-carnitine or salts
11/05/2002US6476006 Compact form for oral administering; bone disorders
11/05/2002US6476004 Pharmaceutical composition
11/05/2002US6475995 Oral delivery of nucleic acid vaccines by particulate complexes
11/05/2002US6475795 Use of hyaluronan in gene therapy
11/05/2002US6475609 Glitter
11/05/2002US6475528 Preparation for regenerating collagen
11/05/2002US6475526 Zinc containing compositions for anti-viral use
11/05/2002US6475524 Composition of matter
11/05/2002US6475519 Oil-free pharmaceutical compositions containing cyclosporin A
11/05/2002US6475510 Process for manufacturing bite-dispersion tablets
11/05/2002US6475507 Sustained release compositions and the process for their preparation
11/05/2002US6475495 Hyperbranched polymers or dendrimers containing a particular group, preparation process, use and compositions comprising them
11/05/2002US6475493 Controlled release pellet formulation
11/05/2002US6475486 Glycosyl-etoposide prodrugs, a process for preparation thereof and the use thereof in combination with functionalized tumor-specific enzyme conjugates
11/05/2002US6475477 Radio-opaque polymer biomaterials
11/05/2002US6475468 Modulated release particles for aerosol delivery
11/05/2002US6475467 Medicinal aerosol formulations
11/05/2002CA2408210A1 Polyurethane and the use thereof for modifying rheological properties
11/05/2002CA2324467C Formulations for protection of peg-interferon alpha conjugates
11/05/2002CA2110166C Tableting of colestipol hydrochloride
11/05/2002CA2049811C Stabilized solid chemical compositions
11/04/2002WO2004001058A2 Transcription factor modulating compounds and methods of use thereof
11/04/2002EP0904109A4 Targeting macromolecular prodrugs to t lymphocytes
10/2002
10/31/2002WO2002086134A2 Buffer solution for electroporation and a method comprising the use of the same
10/31/2002WO2002086074A2 Compositions for delivery of compounds to cells and methods of use
10/31/2002WO2002085951A2 Water soluble, randomly substituted partial n-, partial o-acetylated chitosan, preserving compositions containing chitosan, and processes for making thereof
10/31/2002WO2002085447A2 Microprojection array having a beneficial agent containing coating
10/31/2002WO2002085422A1 Drug delivery matrices to enhance wound healing
10/31/2002WO2002085419A2 Bifunctional-modified hydrogels
10/31/2002WO2002085414A2 Nsaid formulations comprising lecithin oils for protecting the gastrointestinal tract and providing enhanced therapeutic activity
10/31/2002WO2002085387A2 A medicament or a dressing containing a metal such as silver, gold, platinum or palladium as an antimicrobial agent ans their use in the treatment of inflammatory skin conditions
10/31/2002WO2002085386A2 Medicament containing a metal such as silver, gold, platinum or palladium as an antimicrobial agent and their use to induce apoptosis in cancerous tissue
10/31/2002WO2002085385A2 Medicament containing a metal such as silver, gold, platinum or palladium as an antimicrobial agent and their use in the treatment of diseases of the mucosa
10/31/2002WO2002085384A2 Lubricious coatings for substrates
10/31/2002WO2002085371A1 Noninvasive method for treating cellulite through transdermal delivery of calcium channel blocker agents and medicament for use in such method